Literature DB >> 28379416

Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease.

Erik A Williams1, Declan McGuone1, Matthew P Frosch1, Bradley T Hyman1, Nora Laver1, Anat Stemmer-Rachamimov1.   

Abstract

Alzheimer disease (AD) is the most common cause of dementia in the elderly, and is characterized by extracellular deposition of β-amyloid and intracellular accumulation of hyperphosphorylated tau protein in the brain. These pathologic findings are identified postmortem. Various visual deficits in AD have been reported and there have been conflicting reports, through imaging and pathology studies, regarding the presence of changes in the globe that mirror Alzheimer changes in the brain. Moreover, both macular degeneration and glaucoma have been variously characterized as having AD-related features. We examined one or both eyes from 19 autopsy cases, 17 of which had varying degrees of AD-related changes, and 2 of which were age-matched controls. Three cases had glaucoma and 4 had macular degeneration. Immunohistochemistry for tau, β-amyloid, TDP-43, ubiquitin, and α-synuclein showed no evidence of inclusions, deposits or other protein accumulation in any case, in any part of the globe. This finding suggests that regardless of the severity of changes seen in the brain in AD, there are no similar changes in the globe.
© 2017 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Biomarkers; Ocular changes

Mesh:

Substances:

Year:  2017        PMID: 28379416      PMCID: PMC7191616          DOI: 10.1093/jnen/nlx020

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  36 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

Review 2.  Müller cells in the healthy and diseased retina.

Authors:  Andreas Bringmann; Thomas Pannicke; Jens Grosche; Mike Francke; Peter Wiedemann; Serguei N Skatchkov; Neville N Osborne; Andreas Reichenbach
Journal:  Prog Retin Eye Res       Date:  2006-07-12       Impact factor: 21.198

3.  Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Anat Kesler; Veronika Vakhapova; Amos D Korczyn; Elvira Naftaliev; Meira Neudorfer
Journal:  Clin Neurol Neurosurg       Date:  2011-03-31       Impact factor: 1.876

4.  Protein aggregation in the aging retina.

Authors:  François Leger; Pierre-Olivier Fernagut; Marie-Hélène Canron; Sandy Léoni; Claude Vital; François Tison; Erwan Bezard; Anne Vital
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

5.  Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.

Authors:  Swati S More; Robert Vince
Journal:  ACS Chem Neurosci       Date:  2014-11-26       Impact factor: 4.418

Review 6.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

7.  Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.

Authors:  Cheng-Ying Ho; Juan C Troncoso; David Knox; Walter Stark; Charles G Eberhart
Journal:  Brain Pathol       Date:  2013-06-28       Impact factor: 6.508

8.  Alzheimer's Disease and the Early Signs of Age-Related Macular Degeneration.

Authors:  Shaun Frost; Robyn Guymer; Khin Zaw Aung; S Lance Macaulay; Hamid R Sohrabi; Pierrick Bourgeat; Olivier Salvado; Christopher C Rowe; David Ames; Colin L Masters; Ralph N Martins; Yogesan Kanagasingam
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 9.  Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease.

Authors:  Tian Tian; Boai Zhang; Yanjie Jia; Zhaoming Li
Journal:  Dis Markers       Date:  2014-02-12       Impact factor: 3.434

10.  Retinal microvascular network attenuation in Alzheimer's disease.

Authors:  Michael A Williams; Amy J McGowan; Chris R Cardwell; Carol Y Cheung; David Craig; Peter Passmore; Giuliana Silvestri; Alexander P Maxwell; Gareth J McKay
Journal:  Alzheimers Dement (Amst)       Date:  2015-05-16
View more
  18 in total

1.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

2.  Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling.

Authors:  Sumana R Chintapaludi; Asli Uyar; Harriet M Jackson; Casey J Acklin; Xulong Wang; Michael Sasner; Gregory W Carter; Gareth R Howell
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.160

Review 3.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

Review 4.  Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview.

Authors:  María Alejandra Cerquera-Jaramillo; Mauricio O Nava-Mesa; Rodrigo E González-Reyes; Carlos Tellez-Conti; Alejandra de-la-Torre
Journal:  Neural Plast       Date:  2018-10-14       Impact factor: 3.599

5.  Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.

Authors:  Jurre den Haan; Tjado H J Morrema; Annemieke J Rozemuller; Femke H Bouwman; Jeroen J M Hoozemans
Journal:  Acta Neuropathol Commun       Date:  2018-08-09       Impact factor: 7.801

6.  Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

Authors:  Jurre den Haan; Jacoba A van de Kreeke; Elles Konijnenberg; Mara Ten Kate; Anouk den Braber; Frederik Barkhof; Bart N van Berckel; Charlotte E Teunissen; Philip Scheltens; Pieter Jelle Visser; Frank D Verbraak; Femke H Bouwman
Journal:  Alzheimers Dement (Amst)       Date:  2019-06-18

7.  ARCAM-1 Facilitates Fluorescence Detection of Amyloid-Containing Deposits in the Retina.

Authors:  Kevin J Cao; John H Kim; Heike Kroeger; Patricia M Gaffney; Jonathan H Lin; Christina J Sigurdson; Jerry Yang
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

Review 8.  Protein and Imaging Biomarkers in the Eye for Early Detection of Alzheimer's Disease.

Authors:  Shaunt Fereshetian; Joshua S Agranat; Nicole Siegel; Steven Ness; Thor D Stein; Manju L Subramanian
Journal:  J Alzheimers Dis Rep       Date:  2021-05-03

Review 9.  The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.

Authors:  Ana I Ramirez; Rosa de Hoz; Elena Salobrar-Garcia; Juan J Salazar; Blanca Rojas; Daniel Ajoy; Inés López-Cuenca; Pilar Rojas; Alberto Triviño; José M Ramírez
Journal:  Front Aging Neurosci       Date:  2017-07-06       Impact factor: 5.750

10.  Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.

Authors:  Jurre den Haan; Tjado H J Morrema; Frank D Verbraak; Johannes F de Boer; Philip Scheltens; Annemieke J Rozemuller; Arthur A B Bergen; Femke H Bouwman; Jeroen J Hoozemans
Journal:  Acta Neuropathol Commun       Date:  2018-12-28       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.